Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04888845 · ClinicalTrials.gov registry record · NA
Refinement of Suicide Risk Management Intervention
A NA study of Safety Plan and Crisis Response Plan, sponsored by University of Utah.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 2
- Study locations
NCT04888845: Active NA study of Safety Plan and Crisis Response Plan, sponsored by University of Utah.
NCT04888845 is a NA study of Safety Plan and Crisis Response Plan that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04888845, a NA study of Safety Plan and Crisis Response Plan, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
Participants will be randomly assigned to 1 of the 4 interventions using a sequential stratified randomization procedure. We will use sex (M, F) and history of suicide attempts (never, 1, and multiple) as our randomization strata. Participants will be assessed before and after the intervention to study the potential effects of each approach on suicide-related clinical outcomes.
Primary Outcome
Items from the Self Injurious Thoughts and Behaviors questionnaire (Fox et al., 2020) will be used to assess suicide relevant thoughts and behaviors
Conditions Studied
Interventions
- BEHAVIORAL Crisis Response Plan
- BEHAVIORAL Safety Plan
- BEHAVIORAL Structured interview
- BEHAVIORAL Narrative Assessment
Study Locations (2)
Ohio
- The Ohio State - Columbus
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-04-22 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What the registry record for NCT04888845 still lists
NCT04888845 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 4 conditions, with Safety Plan appearing as the primary indexed condition, and to 4 interventions - of which Crisis Response Plan is the first listed.
NCT04888845 reports a single indexed study location in Ohio, Utah.
Frequently Asked Questions
What is clinical trial NCT04888845 about?
NCT04888845 is a clinical study titled "Refinement of Suicide Risk Management Intervention". Participants will be randomly assigned to 1 of the 4 interventions using a sequential stratified randomization procedure. We will use sex (M, F) and history of suicide attempts (never, 1, and multiple) as our randomization strata. Participants will be assessed before and after the intervention to st...
What is the current status of trial NCT04888845?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2021-04-22. Estimated completion is 2026-07-30.
What conditions does trial NCT04888845 study?
This clinical trial studies the following conditions: Safety Plan, Crisis Response Plan, Structured Interview, Narrative Assessment.
What interventions are being tested in trial NCT04888845?
The interventions under investigation include: Crisis Response Plan (BEHAVIORAL), Safety Plan (BEHAVIORAL), Structured interview (BEHAVIORAL), Narrative Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04888845?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04888845 being conducted?
This trial has 2 study locations across Ohio, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Safety Plan
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04888845's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI